Semefab, the Glenrothes CMOS sensor specialist, expects margins to recover this year after making a loss of £582,930 in 2014 on sales that increased 15% to,£9.06 million. In 2013 it made a profit of £127,065.
Semefab attributed the losses to circumstances outside its control:
Extra staff taken on to cope with a rise in orders were not fully productive.
There were unexpected rises in costs particularly energy cost.
Investment in work in progress did not convert to revenue due to unforeseen events.
The plant was shut down for two weeks to comply with a three yearly mandatory Fixed Wiring and Electrical Inspection.
Semefab, Swansea University and a commercial partner are developing a generic platform point of care diagnostic sensor.
Semefab had net current assets and shareholders’ funds of £1,189,619 and £4,051,401 respectively at the end of 2014.
from News http://ift.tt/1DsOnIA
via Yuichun
沒有留言:
張貼留言